Alternatively, species B Ads, which utilize several host cell receptors including CD46 (Ad3/11/35) and desmoglein-2 (Ad3/7/11/14), have been employed to provide more effective cancer targeting [10,14,15,16,17,18]. This evidence concerns the gene CD46 and cancer.